Identification of Small Molecules for Sustained-Release Anti-HIV Products (R01)

The purpose of this Funding Opportunity Announcement (FOA #RFA-AI-16-024) is to solicit applications from single institutions, or consortia of institutions, to identify existing anti-HIV molecules, or discover new highly potent and selective anti-HIV small molecules, with the potential for development as sustained release products (SRP) with a dosing interval from once a week to once every three months or longer.